Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Slides:

Advertisements

Similar presentations

Clinical Infectious Diseases 2012;55(6):764–70 Jan Vydra,1 Ryan M. Shanley,2 Ige George,1 Celalettin Ustun,1 Angela R. Smith,4 Daniel J. Weisdorf,1 and.

Advertisements

Table 3 Clinical response success rate, according to prior effective antimicrobial therapy in hospitalized patients with community-acquired pneumonia given.

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Table 1. Baseline Characteristics of the 36,636 Study Subjects

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Figure 1 Inclusion criteria, exclusion criteria, and criteria for virologic failure. CDC, Centers for Disease Control and Prevention; ddC, zalcitabine;

Table 1 Groups of subjects in a study of the association between antibiotic use and colonization with resistant pneumococci. From: Measuring and Interpreting.

Table 1 Characteristics of patients at enrollment who received artesunate-amodiaquine (ASAQ) or artemether-lumefantrine (AL) for treatment of malaria.

Table 1 Characteristics of the 968 Women in the Study Group

Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.

Table 1 Characteristics of study patients in survey of HIV infection in India. From: Natural History of Human Immunodeficiency Virus Disease in Southern.

Table 3. Predictors of Nevirapine Reactions at Antiretroviral Therapy Initiation From: Strategies for Nevirapine Initiation in HIV-Infected Children Taking.

Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.

Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.

From: Rotarix: A Rotavirus Vaccine for the World

Table 4. Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent.

Figure 4 Monthly all-cause (A-C) and pneumonia and influenza (P&I) mortality rates among Japanese children aged 5–9 years. Vertical dotted lines, January.

Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.

Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,

From: Postinfectious Irritable Bowel Syndrome

Figure 1 Adverse events after typhoid fever vaccination reported to the Vaccine Adverse Events Reporting System, by vaccination date and vaccine type,

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Table 1 Baseline (before receipt of antiretroviral prophylaxis) characteristics of the pregnant women (transmitting or nontransmitting mothers included.

Figure 1 Annual per-capita consumption of all fermented milks and yogurt only in selected countries in Europe and North America [3, 4]. From: Probiotic.

Figure 1 Flow chart distinguishing groups according to receipt of azithromycin treatment and method of data collection. Circles containing the abbreviation.

Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America

Management of multidrug-resistant enterococcal infections

Exploring Factors Associated with Depression and Anxiety among Hospitalized Patients with Type 2 Diabetes Mellitus Med Princ Pract - DOI: /

Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium J. Top, R. Willems, H. Blok, M. de Regt, K.

R. Cantón Clinical Microbiology and Infection

Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium J. Top, R. Willems, H. Blok, M. de Regt, K.

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Genome-based insights into the evolution of enterococci

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

Appropriate vs. inappropriate antimicrobial therapy

A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales

Community-acquired pneumonia: the evolving challenge

Outbreak of vancomycin-resistant Enterococcus spp

Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome M. Mikulska,

Strategies for managing today's infections

Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region K.B. Laupland, D.B. Gregson, D.L. Church,

M. Aires-de-Sousa Clinical Microbiology and Infection

Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study J.-Y. Feng, S.-F. Huang, W.-Y. Ting, Y.-C.

MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.

Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia E.V. Lemos, F.P.

Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study V.

T.M. File Clinical Microbiology and Infection

A.W. Karchmer Clinical Microbiology and Infection

P.M. Hawkey Clinical Microbiology and Infection

Evolving problems with resistant pathogens

Pre-emptive oral ganciclovir can reduce the risk of cytomegalovirus disease in liver transplant recipients J. Torre-Cisneros, J.A. Madueño, C. Herrero,

The dynamic relationship between antibiotic use and the incidence of vancomycin- resistant Enterococcus: time-series modelling of 7-year surveillance data.

Volume 59, Issue 2, Pages (February 2001)

Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit S. Nseir, C. Blazejewski, R. Lubret,

Statin use and clinical outcomes among pneumonia patients

Leishmaniasis in immunosuppressed individuals

E. Tacconelli Clinical Microbiology and Infection

P. Muñoz, J. Palomo, J. Yáñez, E. Bouza

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Surveillance of intestinal colonization and of infection by vancomycin-resistant enterococci in hospitalized cancer patients Florence Moulin, Sandrine.

A. Manzur, F. Gudiol Clinical Microbiology and Infection

Volume 67, Issue 6, Pages (June 2005)

Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci V. Sakka, S. Tsiodras, L. Galani, A. Antoniadou,

Update on invasive aspergillosis: clinical and diagnostic aspects

G.C. Schito Clinical Microbiology and Infection

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Presentation transcript:

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients. From: Vancomycin-Resistant Enterococcal Colonization and Infection in Liver Transplant Candidates and Recipients: A Prospective Surveillance Study Clin Infect Dis. 2006;42(2):195-203. doi:10.1086/498903 Clin Infect Dis | © 2006 by the Infectious Diseases Society of America

Table 5 Comparison of outcomes between patients who did and patients who did not have vancomycin-resistant enterococcal (VRE) colonization prior to transplantation. From: Vancomycin-Resistant Enterococcal Colonization and Infection in Liver Transplant Candidates and Recipients: A Prospective Surveillance Study Clin Infect Dis. 2006;42(2):195-203. doi:10.1086/498903 Clin Infect Dis | © 2006 by the Infectious Diseases Society of America

Table 6 Comparison of outcomes among patients with or without newly acquired vancomycin-resistant enterococcal (VRE) colonization after transplantation. From: Vancomycin-Resistant Enterococcal Colonization and Infection in Liver Transplant Candidates and Recipients: A Prospective Surveillance Study Clin Infect Dis. 2006;42(2):195-203. doi:10.1086/498903 Clin Infect Dis | © 2006 by the Infectious Diseases Society of America

Table 3 Independent risk factors, determined by binary logistic regression, for vancomycin-resistant enterococcal colonization while awaiting liver transplantation. From: Vancomycin-Resistant Enterococcal Colonization and Infection in Liver Transplant Candidates and Recipients: A Prospective Surveillance Study Clin Infect Dis. 2006;42(2):195-203. doi:10.1086/498903 Clin Infect Dis | © 2006 by the Infectious Diseases Society of America

Table 2 Risk factors for colonization with vancomycin-resistant enterococci (VRE) among 375 patients awaiting liver transplantation. From: Vancomycin-Resistant Enterococcal Colonization and Infection in Liver Transplant Candidates and Recipients: A Prospective Surveillance Study Clin Infect Dis. 2006;42(2):195-203. doi:10.1086/498903 Clin Infect Dis | © 2006 by the Infectious Diseases Society of America

Table 1 Demographic and clinical characteristics of 375 liver transplantation candidates enrolled in a study of vancomycin-resistant enterococcal colonization and infection. From: Vancomycin-Resistant Enterococcal Colonization and Infection in Liver Transplant Candidates and Recipients: A Prospective Surveillance Study Clin Infect Dis. 2006;42(2):195-203. doi:10.1086/498903 Clin Infect Dis | © 2006 by the Infectious Diseases Society of America

Table 7 Vancomycin-resistant enterococcal (VRE) infections among liver transplant recipients. From: Vancomycin-Resistant Enterococcal Colonization and Infection in Liver Transplant Candidates and Recipients: A Prospective Surveillance Study Clin Infect Dis. 2006;42(2):195-203. doi:10.1086/498903 Clin Infect Dis | © 2006 by the Infectious Diseases Society of America